PRESS STATEMENT: FOR IMMEDIATE RELEASE Contact: Peggy.Tighe@PowersLaw.com RWC-340B Applauds Court’s “Fairest and Most Reasonable” Interpretation of the 340B Drug Pricing Program: Manufacturer Actions Shall Not Undermine the Safety Net…
On Friday, the U.S. District Court for the Southern District of Indiana (the Court) issued a decision supporting HRSA’s statutory interpretation, as reflected in HRSA’s May 17 determination, that Eli…
On October 25, 2021, drug manufacturer Boehringer Ingelheim Pharmaceuticals, Inc. filed a lawsuit in the U.S. District Court for the District of Columbia against HHS, alleging that HHS’s policy on…
The following article was originally posted on The Parkersburg News and Sentinel’s website, https://www.newsandsentinel.com, on July 13, 2021. Most patients are likely unaware of the ins and outs of the…
Sending Office: Honorable David B. McKinley Sent By: Kirsten.Wing@mail.house.gov Co-Sponsor Bipartisan Legislation to Improve the Health Care Safety Net and Protect 340B Supported by: 340B Health, America’s Essential Hospitals, National…
The following press release was posted on Rep. David B. McKinley’s (R-WV-1) website on May 19, 2021. The press release can be accessed by clicking HERE. WASHINGTON – Today, Reps. David…
PRESS STATEMENT: FOR IMMEDIATE RELEASE Contact: Peggy.Tighe@PowersLaw.com July 9, 2021: RWC-340B, a national association of Ryan White HIV clinics, enthusiastically supports introduction of the PROTECT Act by Representatives McKinley (R-WV)…
By letter dated June 30, 2021, drug manufacturer Boehringer Ingelheim Pharmaceuticals, Inc. notified covered entities that it will no longer honor all 340B contract pharmacy arrangements, effective August 1, 2021. …
The following press release was posted on Rep. David B. McKinley’s (R-WV-1) website on May 19, 2021. The press release can be accessed by clicking HERE. MCKINLEY APPLAUDS DECISION…
Following a favorable May 17 Letter (the “Letter”) issued by HHS requiring six drug companies to restart 340B pricing on drugs shipped to contract pharmacies or risk civil monetary penalties,…